CMS Open Payments · Program Year 2024
Intellijoint Surgical Inc.
Intellijoint Surgical Inc. reported $4,041,598.86 across General Payments, Research, and Ownership to 47 physicians and teaching hospitals across 55 transactions.
- $4.0M Top quartile payer
- All-tracks total
- 55 Below-median volume
- Transactions
- 47 Below-median reach
- Recipients
- −$37.3K
- General Payments vs PY2023
Intellijoint Surgical Inc. reported $4,041,598.86 across all CMS Open Payments tracks (General + Research + Ownership) to 47 physicians and teaching hospitals in Program Year 2024 - ranking #305 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $32,192.06, averaging $86.0K per recipient.
How Intellijoint Surgical Inc.'s $4.0M all-tracks total breaks down
Intellijoint Surgical Inc.'s payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
23/100
Total payments
F
47/100
Transaction volume
F
10/100
Physician reach
F
10/100
Payment type diversity
F
23/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer intellijoint-surgical-inc Intellijoint Surgical Inc.
$4.0M · #305/1,925 · 0.0% industry · PY2024
- TOT $4.0M
- RANK #305
- SHARE 0.0%
- TXN 55
- RCP 47
- CAT 2
- GEN $32.2K
- ΔGEN −$37.3K
- TOP1 70.7%
- PY 2024
Volume peers
Nearest volume peer: ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($4.0M)
Intellijoint Surgical Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Intellijoint Surgical Inc.'s CMS-reported General Payments decreased by $37.3K (−53.7%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: INTELLIJOINT SURGICAL INC.PY2023: INTELLIJOINT SURGICAL INC.PY2024: Intellijoint Surgical Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $69,455.72
- PY2024
- $32,192.06
What the Data Shows for Intellijoint Surgical Inc.
CMS Open Payments is not a single ledger: the all-tracks total shown above is General Payments plus Research Payments plus Ownership/Investment interests, each with its own disclosure rules. For Intellijoint Surgical Inc., that total blends General Payments (day-to-day consulting, meals, travel and speaking fees, shown separately above) with Research and Ownership/Investment interest records, each governed by its own CMS reporting rules. Data for a given Program Year arrives roughly a year after the period it covers; our methodology page documents the release cadence and how we standardize the tracks for cross-company comparison.
Of the 2 general-payment categories charted below, "Consulting Fee" is the largest at $28.9K across 28 transactions, 89.8% of this company's General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
"Consulting Fee" leads Intellijoint Surgical Inc.'s 2-category general-payment breakdown at $28.9K, 89.8% of the reported total.
How Intellijoint Surgical Inc. divides its payments
Ranked by total dollars reported per category
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Consulting Fee | $28.9K | 28 | 89.8% |
| Food and Beverage | $3.3K | 19 | 10.2% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $27,125.00 (84.3%) of $32,192.06 in this company's General Payments records across 28 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Intellijoint Surgical Inc.
The five named recipients with the highest reported General Payments from this company
- 1
Matthew Barber
$22,750.00 across 13 reported transactions
- 2
Michael Bradley
$1,625.00 across 5 reported transactions
- 3
Ran Schwarzkopf
$1,125.00 across 2 reported transactions
- 4
Ritesh Shah
$1,000.00 across 1 reported transactions
- 5
Peter Sculco
$625.00 across 2 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Intellijoint Surgical Inc.'s spend rank (#305 of 1,925, top 16% by spend) and concentration rank (#351 of 1,838, top 19% most concentrated) land at roughly the same percentile, an unusually proportionate case where payment size and payment concentration move together.
View all 12 companies in this HHI neighborhood as a list
- Strategic Dentistry LLC : $1.7K total payments, HHI 5083
- Genmab BV : $51.5K total payments, HHI 5080
- Amnio Technology, LLC : $11.7K total payments, HHI 5078
- New Age Medical LLC : $137.0K total payments, HHI 5077
- Infinity BiologiX LLC : $52.4K total payments, HHI 5072
- Olympus Winter & Ibe GmbH : $34.4K total payments, HHI 5067
- Intellijoint Surgical Inc. (this company) : $32.2K total payments, HHI 5059
- McKesson Corporation : $98.3K total payments, HHI 5044
- Teleflex Incorporated : $670.6K total payments, HHI 5042
- nView medical, Inc : $169.96 total payments, HHI 5033
- Asuragen, Inc. : $4.9K total payments, HHI 5032
- Medynus Inc : $13.0K total payments, HHI 5030
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Intellijoint Surgical Inc.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Intellijoint Surgical Inc..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Intellijoint Surgical Inc..
Showing 6 of 1,924 companies with CMS-reported payment data.
Masimo Corporation
Lundbeck LLC
Impulse Dynamics (USA) Inc.
TransMedics, Inc.
Paragonix Technologies, Inc.
Put this to use
Intellijoint Surgical Inc. ranks #305 of 1,925 by all-tracks total payments, led by "Consulting Fee".
- See where Intellijoint Surgical Inc. sits among every top spender on the full leaderboard. Top 100 by total payments
- Compare "Consulting Fee" spend across every manufacturer, not just Intellijoint Surgical Inc.. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.